• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单细胞 RNA 测序揭示,肿瘤相关成纤维细胞中的 HSD17B2 促进了去势抵抗性前列腺癌的发展和进展。

Single-cell RNA sequencing reveals that HSD17B2 in cancer-associated fibroblasts promotes the development and progression of castration-resistant prostate cancer.

机构信息

Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China.

School of Basic Medical Sciences, Fudan University, Shanghai, China.

出版信息

Cancer Lett. 2023 Jul 10;566:216244. doi: 10.1016/j.canlet.2023.216244. Epub 2023 May 26.

DOI:10.1016/j.canlet.2023.216244
PMID:37244445
Abstract

Castration-resistant prostate cancer (CRPC) responds poorly to existing therapy and appears as the lethal consequence of prostate cancer (PCa) progression. The tumour microenvironment (TME) has been thought to play a crucial role in CRPC progression. Here, we conducted single-cell RNA sequencing analysis on two CRPC and two hormone-sensitive prostate cancer (HSPC) samples to reveal potential leading roles in castration resistance. We described the single-cell transcriptional landscape of PCa. Higher cancer heterogeneity was explored in CRPC, with stronger cell cycling status and heavier copy number variant burden of luminal cells. Cancer-associated fibroblasts (CAFs), which are one of the most critical components of TME, demonstrated unique expression and cell-cell communication features in CRPC. A CAFs subtype with high expression of HSD17B2 in CRPC was identified with inflammatory features. HSD17B2 catalyses the conversion of testosterone and dihydrotestosterone to their less active forms, which was associated with steroid hormone metabolism in PCa tumour cells. However, the characteristics of HSD17B2 in PCa fibroblasts remained unknown. We found that HSD17B2 knockdown in CRPC-CAFs could inhibit migration, invasion, and castration resistance of PCa cells in vitro. Further study showed that HSD17B2 could regulate CAFs functions and promote PCa migration through the AR/ITGBL1 axis. Overall, our study revealed the important role of CAFs in the formation of CRPC. HSD17B2 in CAFs regulated AR activation and subsequent ITGBL1 secretion to promote the malignant behaviour of PCa cells. HSD17B2 in CAFs could serve as a promising therapeutic target for CRPC.

摘要

去势抵抗性前列腺癌(CRPC)对现有治疗反应不佳,似乎是前列腺癌(PCa)进展的致命后果。肿瘤微环境(TME)被认为在 CRPC 进展中起关键作用。在这里,我们对两个 CRPC 和两个激素敏感性前列腺癌(HSPC)样本进行了单细胞 RNA 测序分析,以揭示潜在的抗阉割作用。我们描述了 PCa 的单细胞转录景观。在 CRPC 中探索了更高的癌症异质性,具有更强的细胞循环状态和更多的 luminal 细胞拷贝数变异负担。癌症相关成纤维细胞(CAFs)是 TME 中最关键的成分之一,在 CRPC 中表现出独特的表达和细胞间通讯特征。在 CRPC 中鉴定出一种具有高表达 HSD17B2 的 CAFs 亚型,具有炎症特征。HSD17B2 催化睾酮和二氢睾酮转化为其活性较低的形式,这与 PCa 肿瘤细胞中的类固醇激素代谢有关。然而,PCa 成纤维细胞中 HSD17B2 的特征尚不清楚。我们发现,CRPC-CAFs 中的 HSD17B2 敲低可以抑制 PCa 细胞的迁移、侵袭和抗阉割作用。进一步的研究表明,HSD17B2 可以通过 AR/ITGBL1 轴调节 CAFs 的功能并促进 PCa 迁移。总体而言,我们的研究揭示了 CAFs 在 CRPC 形成中的重要作用。CAFs 中的 HSD17B2 通过 AR/ITGBL1 轴调节 AR 激活和随后的 ITGBL1 分泌,从而促进 PCa 细胞的恶性行为。CAFs 中的 HSD17B2 可以作为 CRPC 的一个有前途的治疗靶点。

相似文献

1
Single-cell RNA sequencing reveals that HSD17B2 in cancer-associated fibroblasts promotes the development and progression of castration-resistant prostate cancer.单细胞 RNA 测序揭示,肿瘤相关成纤维细胞中的 HSD17B2 促进了去势抵抗性前列腺癌的发展和进展。
Cancer Lett. 2023 Jul 10;566:216244. doi: 10.1016/j.canlet.2023.216244. Epub 2023 May 26.
2
Stromal factors involved in human prostate cancer development, progression and castration resistance.参与人类前列腺癌发生、发展和去势抵抗的基质因素。
J Cancer Res Clin Oncol. 2017 Feb;143(2):351-359. doi: 10.1007/s00432-016-2284-3. Epub 2016 Oct 27.
3
Transcript Levels of Androgen Receptor Variant 7 and Ubiquitin-Conjugating Enzyme 2C in Hormone Sensitive Prostate Cancer and Castration-Resistant Prostate Cancer.激素敏感性前列腺癌和去势抵抗性前列腺癌中雄激素受体变异体7和泛素结合酶2C的转录水平
Prostate. 2017 Jan;77(1):60-71. doi: 10.1002/pros.23248. Epub 2016 Aug 22.
4
A 12-gene panel in estimating hormone-treatment responses of castration-resistant prostate cancer patients generated using a combined analysis of bulk and single-cell sequencing data.使用 bulk 和单细胞测序数据的联合分析生成的 12 基因panel 可用于预测去势抵抗性前列腺癌患者的激素治疗反应。
Ann Med. 2023;55(2):2260387. doi: 10.1080/07853890.2023.2260387. Epub 2023 Sep 20.
5
Pre-existing Castration-resistant Prostate Cancer-like Cells in Primary Prostate Cancer Promote Resistance to Hormonal Therapy.原发性前列腺癌中预先存在的去势抵抗性前列腺癌细胞样细胞促进对激素治疗的抵抗。
Eur Urol. 2022 May;81(5):446-455. doi: 10.1016/j.eururo.2021.12.039. Epub 2022 Jan 17.
6
Cancer-associated fibroblasts promote prostate tumor growth and progression through upregulation of cholesterol and steroid biosynthesis.癌相关成纤维细胞通过上调胆固醇和类固醇生物合成促进前列腺肿瘤生长和进展。
Cell Commun Signal. 2020 Jan 24;18(1):11. doi: 10.1186/s12964-019-0505-5.
7
Identification of cancer-associated fibroblasts subtypes in prostate cancer.鉴定前列腺癌中的癌症相关成纤维细胞亚型。
Front Immunol. 2023 Mar 24;14:1133160. doi: 10.3389/fimmu.2023.1133160. eCollection 2023.
8
LMO2 upregulation due to AR deactivation in cancer-associated fibroblasts induces non-cell-autonomous growth of prostate cancer after androgen deprivation.由于雄激素受体失活导致癌症相关成纤维细胞中 LMO2 的上调,在雄激素剥夺后诱导前列腺癌的非细胞自主生长。
Cancer Lett. 2021 Apr 10;503:138-150. doi: 10.1016/j.canlet.2021.01.017. Epub 2021 Jan 24.
9
The ADAM9/UBN2/AKR1C3 axis promotes resistance to androgen-deprivation in prostate cancer.ADAM9/UBN2/AKR1C3轴促进前列腺癌对雄激素剥夺的抗性。
Am J Cancer Res. 2022 Jan 15;12(1):176-197. eCollection 2022.
10
Analytical Validation and Clinical Qualification of a New Immunohistochemical Assay for Androgen Receptor Splice Variant-7 Protein Expression in Metastatic Castration-resistant Prostate Cancer.一种用于检测转移性去势抵抗性前列腺癌中雄激素受体剪接变体-7蛋白表达的新型免疫组织化学检测方法的分析验证和临床鉴定
Eur Urol. 2016 Oct;70(4):599-608. doi: 10.1016/j.eururo.2016.03.049. Epub 2016 Apr 23.

引用本文的文献

1
Landscape analysis of matrix metalloproteinases reveals key prognostic markers for prostate cancer.基质金属蛋白酶的景观分析揭示了前列腺癌的关键预后标志物。
Front Immunol. 2025 Jun 18;16:1582992. doi: 10.3389/fimmu.2025.1582992. eCollection 2025.
2
Role of Tumor Microenvironment in Prostate Cancer Immunometabolism.肿瘤微环境在前列腺癌免疫代谢中的作用
Biomolecules. 2025 Jun 6;15(6):826. doi: 10.3390/biom15060826.
3
Single-cell sequencing unveils the transcriptomic landscape of castration-resistant prostate cancer-associated fibroblasts and their association with prognosis and immunotherapy response.
单细胞测序揭示了去势抵抗性前列腺癌相关成纤维细胞的转录组景观及其与预后和免疫治疗反应的关联。
BMC Cancer. 2025 Apr 30;25(1):813. doi: 10.1186/s12885-025-14212-x.
4
Analysis of comb morphology in Sichuan Mountaineous Black-bone chickens and its correlation with growth performance.四川山地乌骨鸡鸡冠形态分析及其与生长性能的相关性
Poult Sci. 2025 Jul;104(7):105168. doi: 10.1016/j.psj.2025.105168. Epub 2025 Apr 17.
5
Inhibition of stromal MAOA leading activation of WNT5A enhance prostate cancer immunotherapy by involving the transition of cancer-associated fibroblasts.抑制基质单胺氧化酶A导致WNT5A激活,通过涉及癌症相关成纤维细胞的转变来增强前列腺癌免疫治疗。
J Immunother Cancer. 2025 Mar 22;13(3):e010555. doi: 10.1136/jitc-2024-010555.
6
Tumor-associated macrophage-derived exosome miR-194 confers cisplatin resistance in GC cells.肿瘤相关巨噬细胞衍生的外泌体miR-194赋予胃癌细胞顺铂耐药性。
Eur J Med Res. 2025 Feb 4;30(1):75. doi: 10.1186/s40001-025-02329-5.
7
Primary Cilia Formation Mediated by Hsa_Circ_0005185/OTUB1/RAB8A Complex Inhibits Prostate Cancer Progression by Suppressing Hedgehog Signaling Pathway.由Hsa_Circ_0005185/OTUB1/RAB8A复合物介导的初级纤毛形成通过抑制刺猬信号通路抑制前列腺癌进展。
Adv Sci (Weinh). 2025 Feb;12(8):e2411675. doi: 10.1002/advs.202411675. Epub 2025 Jan 9.
8
MHC class I upregulation contributes to the therapeutic response to radiotherapy in combination with anti-PD-L1/anti-TGF-β in squamous cell carcinomas with enhanced CD8 T cell memory-driven response.在具有增强的CD8 T细胞记忆驱动反应的鳞状细胞癌中,MHC I类分子上调有助于放疗联合抗PD-L1/抗TGF-β治疗反应。
Cancer Lett. 2025 Jan 1;608:217347. doi: 10.1016/j.canlet.2024.217347. Epub 2024 Nov 22.
9
Application and new findings of scRNA-seq and ST-seq in prostate cancer.单细胞RNA测序和空间转录组测序在前列腺癌中的应用及新发现
Cell Regen. 2024 Oct 29;13(1):23. doi: 10.1186/s13619-024-00206-w.
10
Identification of KLHL17 as a prognostic marker for prostate cancer based on single-cell sequencing and in vitro/in vivo experiments.基于单细胞测序及体内外实验鉴定KLHL17作为前列腺癌的预后标志物
Discov Oncol. 2024 Oct 4;15(1):524. doi: 10.1007/s12672-024-01406-1.